HEPATIC CELL PROLIFERATION PEAKS ONE WEEK AFTER PORTAL VEIN LIGATION AND IS NOT ENHANCED BY INSULIN (EXPERIMENTAL STUDY)

Authors

  • Marta Guimarães Dep of General Surgery, Centro Hospitalar de Entre o Douro e Vouga; Centro Experimental de Cirurgia Avançada, Vila do Conde, Portugal; Dep of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto http://orcid.org/0000-0001-8094-7197
  • Tiago Morais Dep of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto http://orcid.org/0000-0003-4905-706X
  • Sofia S. Pereira Dep of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto http://orcid.org/0000-0001-6947-4560
  • Ana Monteiro Escola Superior de Tecnologia da Saúde do Porto
  • Ana Vilaça João Carlos Costa, Diagnóstico por Imagem, Gondomar, Portugal
  • Tiago Ferreira Dep of General Surgery, Centro Hospitalar de Entre o Douro e Vouga; Centro Experimental de Cirurgia Avançada, Vila do Conde, Portugal
  • Tiago Castro Dep of General Surgery, Centro Hospitalar de Entre o Douro e Vouga; Centro Experimental de Cirurgia Avançada, Vila do Conde, Portugal http://orcid.org/0000-0002-8534-558X
  • Pedro Rodrigues Dep of General Surgery, Centro Hospitalar de Entre o Douro e Vouga; Centro Experimental de Cirurgia Avançada, Vila do Conde, Portugal
  • Vera Oliveira Dep of General Surgery, Centro Hospitalar de Entre o Douro e Vouga; Centro Experimental de Cirurgia Avançada, Vila do Conde, Portugal
  • Mário Nora Dep of General Surgery, Centro Hospitalar de Entre o Douro e Vouga; Centro Experimental de Cirurgia Avançada, Vila do Conde, Portugal
  • Artur Águas Dep of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto http://orcid.org/0000-0002-1487-9517
  • Mariana Monteiro Dep of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto http://orcid.org/0000-0002-0662-1831
  • Gil Gonçalves Dep of General Surgery, Centro Hospitalar de Entre o Douro e Vouga

DOI:

https://doi.org/10.34635/rpc.576

Keywords:

partial hepatectomy, portal vein ligation, insulin, proliferation

Abstract

Introduction: Selective portal vein ligation is currently used to induce hypertrophy of healthy liver segments before partial hepatectomy performed to treat metastatic or primary liver cancer. A major limitation of this procedure is the time interval needed between the portal ligation and hepatic resection, potentially leading to tumour progression. We report the characterization of the liver regeneration kinetics after portal ligation on a rat model, also testing the usefulness of insulin to accelerate liver hypertrophy after the procedure.

Materials and Methods: Liver function and morphology in male Wistar rats was evaluated 1, 2 or 4 weeks after portal ligation alone or with concomitant continuous intraperitoneal insulin infusion and compared to those of intact controls.

Results: Selective portal vein ligation induced ipsilateral lobe atrophy and contralateral lobe hypertrophy. In this model, liver lobe hypertrophy reached its peak at 1 week after portal ligation (PVL:0,13cm; PVL+Insulin:0,34cm) and insulin infusion had no significant additional effect on the liver response to portal ligation.

Discussion and conclusion: Hepatocyte proliferation after selective portal ligation was a fast phenomenon, peaking as early as 1 week after the procedure. Insulin was not useful as adjuvant therapy to further increase hepatocyte proliferation after portal ligation in the rat. 

Downloads

Download data is not yet available.

References

Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545-1559.

Elias D, Goere D, Kohneh-Sahrhi N, de Baere T. Strategies for resection using portal vein embolization: metastatic liver cancer. Seminars in interventional radiology 2008;25:123-131.

Lainas P, Boudechiche L, Osorio A, Coulomb A, Weber A, Pariente D, et al. Liver regeneration and recanalization time course following reversible portal vein embolization. J Hepatol 2008;49:354-362.

Breitenstein S, Apestegui C, Petrowsky H, Clavien PA. "State of the art" in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg. 2009;33:797-803.

Tseng JH, Ouyang CH, Lin KJ, Yeh TS. Significance of insulin signaling in liver regeneration triggered by portal vein ligation. J Surg Res. 2011;166:77-86.

Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nagino M. Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg 2012;29:23-29.

Fausto N. Liver regeneration. J Hepatol. 2000;32:19-31.

Trotter NL. Electron-opaque, lipid-containing bodies in mouse liver at early intervals after partial hepatectomy and sham operation. J Cell Biol. 1965;25:Suppl:41-52.

Leveille GA, Chakrabarty K. Diurnal variations in tissue glycogen and liver weight of meal-fed rats. J Nutr. 1967;93:546-554.

Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg. 2004;139:766-774.

Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology. 2000;31:255-260.

Liska V, Treska V, Mirka H, Kobr J, Sykora R, Skalicky T, et al. Interleukin-6 augments activation of liver regeneration in porcine model of partial portal vein ligation. Anticancer Res. 2009;29:2371-2377.

Downloads

Published

2020-09-30

Issue

Section

Original Papers

Most read articles by the same author(s)